Sam Lee - Cocrystal Pharma Insider

Cocrystal Pharma Inc -- USA Stock  

USD 0.2645  0.0055  2.04%

Co-Founder and Pres

Dr. Sam Lee is the President of Cocrystal Pharma, Inc. Dr. Lee has served as President of Cocrystal since January 2, 2014. From January 2, 2014 until November 22, 2014, He was a director of Cocrystal. He is a cofounder of Cocrystal Discovery and was President and a director of Cocrystal Discovery since 2007. He has 17 years of antiinfective drug discovery research experience. Prior to being a cofounder of Cocrystal, he managed antiinfective, oncology, and inflammation drug discovery projects for eight years at ICOS Corporationrationration
Age: 55  Founder Since 2014  Ph.D    
678-892-8800  http://www.cocrystalpharma.com
Lee was responsible for incorporating protein crystallography and structural biology approaches into ICOS research. He received his Ph.D. in Biological Sciences from the University of Notre Dame, and completed postdoctoral training in viral replication biochemistry with Dr. I. R. Lehman at Stanford University. While at Stanford, Dr. Lee founded and was CEO of Viral Assays in Cupertino, CA.

Management Efficiency

The company has return on total asset (ROA) of (36.83) % which means that it has lost $36.83 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (52.95) % meaning that it created substantial loss on money invested by shareholders.

Entity Summary

Cocrystal Pharma, Inc., a preclinicalstage biopharmaceutical company, intends to develop medicines for use in treating human viral diseases. Cocrystal Pharma Inc (COCP) is traded on OTC Market in USA. It is located in Cocrystal Pharma, Inc.Tucker, GA and employs 23 people.

Did you try this?

Run Equity Forecasting Now
   

Equity Forecasting

Use basic forecasting models to generate price predictions and determine price momentum
Hide  View All  Next  Launch Equity Forecasting
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Cocrystal Pharma Inc to your portfolio

Top Management

Cocrystal Pharma Inc Leadership Team
Curtis Dale, CFO
Steven Rubin, Director
Sam Lee, Founder, Ph.D
Raymond Schinazi, Director, CFA
Gary Wilcox, Chairman, Ph.D
James Martin, CFO
Jeffrey Meckler, CEO
Phillip Frost, Director
David Block, Director
Douglas Mayers, Executive
Walt Linscott, Director
Jane Hsiao, Director, Ph.D
Gerald McGuire, CFO

Stock Performance

Cocrystal Pharma Performance Indicators